NCT00703742View on ClinicalTrials.gov

A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
DepressionDepression Secondary to Other Disease
Interventions
DRUG

Escitalopram

A,1: Escitalopram, oral, 20 mg/day, 8 weeks

Trial Locations (1)

650031

The First Affiliated Hospital of Kunming Medical College, Kunming

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Kunming Medical University

OTHER

NCT00703742 - A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression | Biotech Hunter | Biotech Hunter